Literature DB >> 1692049

Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen.

D Proud1, J Sweet, P Stein, R A Settipane, A Kagey-Sobotka, M H Friedlaender, L M Lichtenstein.   

Abstract

To evaluate the role of inflammatory mediators in the pathogenesis of the ocular allergic response, 23 subjects with positive histories of allergies to either cat dander or ragweed pollen and positive skin tests to the appropriate allergen extract were recruited and were subjected to conjunctival provocation. The tear duct of the left eye of each subject was blocked with a collagen plug while the right eye was left unplugged. In all cases, the eye was initially provoked with saline and subsequently with the appropriate allergen extract. Nonallergic subjects, or allergic subjects provoked with nonrelevant allergen, were used as control subjects. After each provocation, symptoms were recorded, and tears were collected with preweighed strips of filter paper (Schirmer strip). Each strip was placed into a tared tube containing fluid appropriate for the optimal preservation of the mediator to be measured. It was therefore possible to calculate the weight of tears collected and to express mediator levels per milliliter of tears. All allergic subjects demonstrated a positive symptomatic response to allergen challenge, whereas the control subjects remained asymptomatic. Blockage of the tear duct did not significantly alter the response. For allergic subjects, the levels of histamine, kinins, prostaglandin D2, albumin, and TAME-esterase activity were all significantly (p less than 0.005 in each case) greater after allergen challenge than after saline challenge. Furthermore, levels of each of these mediators after allergen challenge (expressed as increases above levels after saline provocation) were significantly greater for allergic subjects than for control subjects (p less than 0.005 in each case). Thus, the clinical response to conjunctival provocation with allergen is associated with increases in the levels of inflammatory mediators in tears.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692049     DOI: 10.1016/0091-6749(90)90075-f

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  20 in total

Review 1.  Ocular mast cells. Characterization in normal and disease states.

Authors:  E B Cook; J L Stahl; N P Barney; F M Graziano
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

Review 2.  Conjunctival allergen challenge: models in the investigation of ocular allergy.

Authors:  Mark B Abelson; Oliver Loeffler
Journal:  Curr Allergy Asthma Rep       Date:  2003-07       Impact factor: 4.806

3.  Some unusual nonallergic causes of giant papillary conjunctivitis.

Authors:  M H Friedlaender
Journal:  Trans Am Ophthalmol Soc       Date:  1990

Review 4.  Allergic eye disease mechanisms.

Authors:  J I McGill; S T Holgate; M K Church; D F Anderson; A Bacon
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

5.  Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810.

Authors:  Najam A Sharif
Journal:  ACS Pharmacol Transl Sci       Date:  2020-11-05

Review 6.  Proinflammatory Pathways in the Pathogenesis of Asthma.

Authors:  R Stokes Peebles; Mark A Aronica
Journal:  Clin Chest Med       Date:  2019-03       Impact factor: 2.878

Review 7.  A review of the use of olopatadine in allergic conjunctivitis.

Authors:  James I McGill
Journal:  Int Ophthalmol       Date:  2004-05       Impact factor: 2.031

8.  NPR-B natriuretic peptide receptors in human corneal epithelium: mRNA, immunohistochemistochemical, protein, and biochemical pharmacology studies.

Authors:  Parvaneh Katoli; Najam A Sharif; Anupam Sule; Slobodan D Dimitrijevich
Journal:  Mol Vis       Date:  2010-07-07       Impact factor: 2.367

9.  Protective effects of deflazacort on allergen-specific conjunctival challenge.

Authors:  G Ciprandi; S Buscaglia; A Iudice; G P Pesce; M Bagnasco; G W Canonica
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Human conjunctival epithelial cell responses to platelet-activating factor (PAF): signal transduction and release of proinflammatory cytokines.

Authors:  Najam A Sharif; Shouxi Xu; Peggy E Hellberg; Iok-Hou Pang; Daniel A Gamache; John M Yanni
Journal:  Mol Vis       Date:  2009-06-06       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.